N-acetyl-eH)-mannosamine (26.6 Ci/mmol) was purchased from New England Nuclear, Boston, MA. N-acetyl- (4, 5, 6, 7, 8, 9 -14C)-neuraminic acid (200 mCi/mmol) was from Amersham (Buckinghamshire, England). Unlabeled NANA and ManNAc were obtained from Sigma (Munich, FRG) and digitonin from Merck (Darmstadt, FRG). Culture medium, enzyme solutions, and additions for the culture media were from Serva (Heidelberg, FRG). All other reagents were of analytical grade and obtained from commercial sources.
Cell culture. A fibroblast cell strain was established from a male infant with ISSD diagnosed in our laboratory. A detailed description of clinical, morphological, and biochemical findings will be published elsewhere. In brief, the patient presented with marked hepatosplenomegaly and severe progressive mental and motor retardation. Peripheral lymphocytes and cultured fibroblasts showed pronounced vacuolization. The activities of lysosomal enzymes including sialidase were found to be normal. Ten-to 30-fold levels of free NANA in urine, leucocytes, and cultured fibroblasts confirmed the diagnosis.
Stock cultures were grown in Eagle's basal medium supplemented with Earle's salts, 10% fetal calf serum and 2 mM glutamine (standard medium) as previously described (8) . Subcultures were plated in 60-mm dishes and grown to confluency.
Metabolic labeling of NANA. For pulse-chase experiments growth medium was removed, cells washed with phosphatebuffered saline and incubated for up to 72 h at 37" C with 2 ml of a modified standard medium containing 13 % fetal calf serum, reduced glucose concentration (0.48 mM), 25 mM Hepes, 10 773 ABSTRACT. N-acetyl-eH)-mannosamine leH)-ManNAc) was used as a precursor for the metabolic labeling of Nacetyl-eH)-neuraminic acid IeH)-NANA) in cultured fibroblasts of a patient with infantile sialic acid storage disease (ISSD). The metabolic fate of free and bound eH)-NANA, isolated by high-performance liquid chromatography, was followed under pulse-chase labeling conditions. Nonsaturable accumulation of free eH)-NANA was observed in ISSD, while the metabolic flux from eH)-ManNAc to NANA-glycoconjugates was unaffected. Accumulated free eH)-NANA could not effectively be chased from ISSD cells although N-acetyl-eH)-hexosamines leH)-HexNAc) were appearing in the chase medium. These metabolites could arise from eH)-NANA bound to glycoconjugates which were cleaved at normal rates in ISSD. The finding that free eH)-NANA was markedly increased relative to its major products eH)-HexNAc is suggestive for an impaired degradation and reutilization of eH)-NANA due to trapping in a metabolically unaccessible pool. In titration experiments with digitonin a clear-cut increase in the latency of labeled NANA relative to a cytoplasmic marker enzyme was evident in ISSD. The release of eH)-NANA, however, followed closely the digitonin-induced release of the lysosomal enzyme {1-hexosaminidase. This is suggestive for a lysosomal location of the stored material. (Pediatr Res 20: 773-777,1986) Abbreviations ISSD, infantile sialic acid storage disease NANA, N-acetyl-neuraminic acid ManNAc, N-acetyl-mannosamine HexNAc, N-acetyl-hexosamines TCA, trichloracetic acid HPLC, high performance liquid chromatography LDH, lactate dehydrogenase {1-HEX, {1-N-acetylhexosaminidase HVE, high voltage electrophoresis ISSD has recently been identified as a very rare inherited disturbance in sialic acid metabolism (I, 2). This condition is characterized by hepatosplenomegaly and severe mental and motor retardation of early onset accompanied by a pronounced tissue storage and hyperexcretion of free sialic acid (NANA). mM NaHC03, and 50 JICi/ml eH)-ManNAc (specific activity 26.6 Ci/mmol).
In chase experiments the radioactive medium was replaced by 2 ml of standard growth medium after extensive washing with phosphate-buffered saline. At the times indicated the cells were harvested by trypsinization, collected by centrifugation, sonicated in 0.5 ml of water, and further processed exactly as described (9) . In brief, after addition of appropriate carrier compounds, TCA-soluble supernatants were analysed for free eH)-NANA. TCA pellets were subjected to hydrolysis with trifluoroacetic acid. Released eH)-NANA was taken as a measure for total NANA-sialoglycoconjugates [bound eH)-NANA]. In analogy, radioactive chase media were treated with TCA and processed according to the same protocol. Final fractions were lyophilized and reconstituted in 300 JIl bidistilled water.
Analyses. Isolation ofeH)-NANA was accomplished by HPLC (3). One hundred-JIl aliquots of the radioactive material were chromatographed on a HPX-87 H column (300 x 7.8 mm !D, Biorad Laboratories, Vienna, Austria) equipped with a guard cartridge (40 x 4.6 mm ID). Isocratic elution was performed at 22°C for 15 min with 0.0045 N H 2 S04 (pH 2.5) at a flow rate of 0.6 ml/min. Fractions of 0.4 ml were collected and assessed for radioactivity by liquid scintillation counting. eH)-NANA was eluted as a single peak at a retention time of 7 min coeluting with unlabeled NANA as detected by UV absorption at 200 nm (pool I). Another radioactive peak (pool II) eluted at a retention time identical to that of eH)-labeled or unlabeled ManNAc standard.
Radioactive fractions were subjected to ion exchange chromatography on Dowex 1 x 8 (9), thin-layer chromatography (10) and HVE at pH 5.5 (13) to confirm identity and purity. Authentic standards eluted from the HPLC column in the following order: NANA, 2,3-dehydro-NANA, ManNAc, glucosamine, mannose, galactose, and fucose.
Digitonin titration experiments.
It has repeatedly been shown that digitonin makes membranes permeable by forming a complex with cholesterol (11, 12). The plasma membrane appears to be especially susceptible for leakage even at very low digitonin concentrations. Therefore, we attempted to define conditions for a maximal release of cytosolic components while leaving lysosomal structures largely intact: After metabolic labeling with eH)-ManNAc for 4 days cells were harvested by trypsinization, centrifuged, and carefully resuspended in Ca++ and Mg++-free Hanks' solution supplemented with 10 mM Hepes (pH 7.0), 0.1 % bovine serum albumin, I mM EDTA (12) .
Aliquots containing approximately 400 Jig of cell protein/ml and up to 50 JIg/ml digitonin were prepared with the same buffer.
Suspensions were incubated under gentle shaking for 7.5 min at 2Y C. Digitonin exposure was terminated by rapid centrifugation at 12,000 x g in an Eppendorf centrifuge for 30 s. Pellets and supernatants were separated immediately and analyzed for LDH and fI-HEX activities by standard methods (13, 14) . eH)-NANA was analyzed in the same fractions as described above. The sum of digitonin soluble and digitonin resistant fractions was taken as 100% both for enzyme activities and eH)-NANA content.
RESULTS
Highly specific metabolic labeling of NANA can be achieved by the use of eH)-ManNAc as radioactive precursor for phosphorylation and aldol condensation with phosphoenolpyruvate (13) .
Incubation of fibroblasts with eH)-ManNAc for up to 3 days and subsequent HPLC isolation of radioactive products in cells and media by HPLC revealed two major peaks that eluted within 15 min ( 1 x 8 (9) and subsequent thin layer chromatography (10). The second peak (pool II) had the same retention time as ManNAc on HPLC. On HYE two radioactive peaks with a mobility identical to C 4 C)-NANA and eH)-ManNAc were detected. Their quantitative relationship was very close to HPLC results. Pool II showed no electrophoretic mobility, as is described for N-acetylhexosamines (6, 13) (data not shown).
Representative HPLC elution profiles of TCA soluble intracellular radioactivity after 48 h of pulse labeling and after a 24 h chase incubation are depicted in Figure lA and B. Under both conditions a marked accumulation of eH)-NANA (pool I) was evident in ISSD cells while pool II showed a marked decay during the chase incubation. Analysis of the medium after a 72-h chase (Fig. 1C ) revealed large amounts of pool II but also a small eH)-NANA peak, at least in ISSD cells.
Following the time course of pulse labeling in normal fibroblasts the accumulation ofeH)-NANA approached a steady state within 48 h (Fig. 2A) .
In ISSD cells eH)-NANA increased 5-to lO-fold above control levels without reaching an equilibrium after 3 days. No significant difference in the amount of bound eH)-NANA, liberated by trifluoroacetolysis from the TCA pellets, was observed (Fig.  2B) . So far, these results confirm the previous data of Thomas et at. (9) .
In chase experiments, free intracellular eH)-NANA decreased by 80% within 2 days in controls while no loss at all was observed in ISSD (Fig. 3A) . A slight increase in the amount of stored eH)-NANA was observed within the initial chase period. In contrast, intracellular bound eH)-NANA showed a normal disappearance rate in ISSD (Fig. 3B) . This is in agreement to the finding of normal sialidase activities in our patient (not shown).
Small amounts of eH)-NANA were detected in the chase media being markedly higher in ISSD (Fig. 3D) . Bound eH)-NANA of culture media increased at a somewhat lower rate than in controls (Fig. 3£ ). As shown above (Fig. 1C) , the radioactivity in the medium after 72 h of chase incubation consisted almost exclusively (>98%) of eH)-N-acetylhexosamines (pool II) in control cells. This is in marked contrast to the data in ISSD, where approximately 20% of total eH) counts are associated with the NANA peak (pool I). The relative amount of radioac- tivity expressed as the ratio of pool lover pool II varied with increasing chase time ( Fig. 3C and F) . At any time point this value was elevated and showed a marked increment with increasing chase time in ISSD cells.
Thus our results demonstrate an intracellular accumulation and an impaired metabolic utilization ofbiosynthetically labeled free eH)-NANA. These findings might be explained by an intralysosomal trapping of free eH)-NANA as previously suggested (2, 6) . In order to establish a difference in the subcellular distribution, the latency of free intracellular eH)-NANA after exposure to digitonin was investigated (Fig. 4) .
When fibroblast suspensions were exposed to digitonin concentrations above 7.5 JLg/mg cell protein, LDH was solubilized almost quantitatively (more than 90%). Under these conditions only 20 to 35% of iJ-HEX were extracted. Both cell lines showed identical enzyme release in response to the detergent. In contrast, the shape of the latency curve of eH)-NANA was clearly different. In ISSD (panel B) the eH)-NANA release closely followed the lysosomal marker enzyme.
A rough estimation of the quantitative distribution of free eH)-NANA between the LDH-associated ("cytosolic") and 13-HEX-associated ("lysosomal") compartments was made on the basis of the following assumptions: I) The recovery of digitoninsoluble eH)-NANA is comparable to the recovery of digitoninsoluble marker enzymes.
2) The activity of iJ-HEX can be taken as an indicator for a minor leakage of intralysosomal material occurring at low digitonin concentrations ("carry over").
The amount of free eH)-NANA found in the supernatants or in the digitonin-resistent cell pellets was related to the percentage of the marker enzymes in the same fractions. At any given digitonin concentration, which resulted in a clear-cut difference in the distribution between LDH and iJ-HEX, two equations with two unknowns allowed us to quantitate the LDH-associated and iJ-HEX associated eH)-NANA content (Table 1) . Based on these calculations the main portion (73%) of stored eH)-NANA resides in the "lysosomal compartment" in ISSD. This is in marked contrast to control cells which showed a reverse relative distribution of eH)-NANA (68% in the "cytoplasmic compartment"). Moreover, in controls, the absolute amount of eH)-NANA associated with iJ-HEX was only 5% of that of ISSD cells.
DISCUSSION
This work is concerned with the transport and utilization of NANA in cultured fibroblasts of a patient with ISSD. Since NANA itself is poorly incorporated into intact cells (13) we made use of the precursor eH)-ManNAc for the relatively specific metabolic labeling of NANA (10) . In normal cells eH)-NANA accl:lI?u~ation reached. a plateau within 3 days indicating an eqUlhbnum between bIOsynthesis and degradation ( Fig. 2A) . In ISSD, however, the cellular accumulation of eH)-NANA was n~t saturable within~days,~hich is consistent with the hypotheSIs that a concentratIOn gradient for eH)-NANA is continuously maintained in favor of the intracellular compartment.
Following the fate ofbound eH)-NANA (Fig. 2B) we observed a nearly l~near inc~ease with time in both phenotypes showing that the blOsynthetIc flux from eH)-ManNAc via cytidine monophosphate-NANA to NANA-glycoconjugates is apparently unaffected in ISSD. This is in agreement with the finding of normal cytidine mon?phosphate-NANA levels in ISSD fibroblasts (9) . In controls, Incorporated eH)-NANA was effectively chased In contrast, no substantial decrease of intracellular-free CH)-NANA was observed in ISSD cells during chase incubations. CH)-NANA bound to glycoconjugates, however, was apparently cleaved at normal rates in ISSD (Fig. 3B) . It is conceivable that during a chase incubation with unlabeled medium CH)-NANA is not only diluted in its specific activity but also further metabolized. The use of a sensitive HPLC method allowed us to analyze the content ofCH)-NANA and of its major catabolic products CH)-HexNAc in the chase media. As evidenced in Figure IC relatively large amounts of CH)-HexNAc were found in the chase media of both phenotypes. Since the absolute amounts were exceeding those observed after the pulselabeling period (Fig. IA) one could speculate that CH)-HexNAc is arising due to metabolic conversion of CH)-NANA by a NANA-pyruvate lyase. So far, however, we and others (5, 6) have not been able to detect this enzyme activity in fibroblast homogenates. CH)-HexNAc in the chase medium ofISSD fibroblasts might stem from the cleavage of bound CH)-NANA by normal acting lysosomal sialidases and subsequent conversion via the pathway mentioned. Theoretically, extracellular enzyme activities could also contribute to metabolite levels of the media.
In contrast to Hancock et at. (6), we were able to detect small amounts ofCH)-NANA in the media ofISSD cells. This finding is open to a number of explanations, e.g. excretion to the culture medium, exchange from the cytoplasmic pool, release by media neuraminidase from surface sialilated glycoconjugates, or cell death after prolonged culture at confluency. Regardless the exact mode of CH)-NANA catabolism, the observation of markedly increased CH)-NANAICH)-HexNAc ratios in the intra-and extracellular compartments (Fig. 3C and F) of ISSD cells provides evidence that CH)-NANA is less accessible to the processes of degradation and reutilization. The clear-cut difference in the distribution of CH)-NANA relative to the marker enzymes LDH and {J-HEX observed in the digitonin titration experiments (Fig.  4 ) strongly indicates that trapping ofCH)-NANA in ISSD occurs within a digitonin-resistant compartment, presumably representing lysosomes. The quantitative data calculated by use of digitonin titration curves are in good agreement with data derived from subcellular fractionation studies (6) .
In our experiments we observed nonsaturable accumulation of metabolically labeled free CH)-NANA in ISSD fibroblasts. Although the exact molecular mechanism of this phenomenon remains to be elucidated our data are consistent with the hypothesis that this accumulation is determined by concentrating free CH)-NANA within the lysosomal compartment. Our experiments also support the view that intralysosomal trapping of free CH)-NANA leads to impaired NANA catabolism and reutilization.
